However, Stryker’s overall net sales remained relatively flat (0.1 percent decrease) on a constant currency bias.
The company’s orthopedic implant sales increased 5.1 percent on a constant currency basis, and medical/surgical equipment sales decreased 7.7 percent on a constant currency basis.
Stryker anticipates an unfavorable impact on net sales of approximately 1.5-2.5 percent in the third quarter of 2009 and an unfavorable impact on net sales of approximately 2-3 percent for the full year of 2009, according to the release.
Read the release on Stryker’s Q2 earnings.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
